Trial
NCT02457026
Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
Bausch & Lomb Incorporated
Condition
Neovascular Age-related Macular Degeneration
Intervention
Aflibercept
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-26